Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Nissay Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 292
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 202
Rounds per year 9.42
Lead investments 49
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 31
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Internet
  • Software
  • E-Commerce
  • Information Technology
Summary

In 1991 was created Nissay Capital, which is appeared as VC. The main department of described VC is located in the Tokyo. The fund was located in Asia if to be more exact in Japan.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Among the most successful fund investment fields, there are Crowdsourcing, Software. Among the most popular portfolio startups of the fund, we may highlight Raksul, Sansan, Itandi.

The overall number of key employees were 2.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Nissay Capital, startups are often financed by Incubate Fund, CyberAgent Capital, Archetype Ventures. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, Nippon Venture Capital, Innovation Network Corporation of Japan. In the next rounds fund is usually obtained by SMBC Venture Capital, Innovation Network Corporation of Japan, SBI Investment.

The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this Nissay Capital works on 22 percentage points less the average amount of lead investments.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Nissay Capital:
Typical Co-investors
Nissay Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Nissay Capital:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

LUCA Science

Biotechnology
Health Care
Pharmaceutical
$35M06 Jun 2022 Chiyoda, Japan

Fez Japan

Media and Entertainment
Retail
$10M13 Oct 2021 Chiyoda, Japan

Wakaze

Brewing
Wine And Spirits
$3M12 Jun 2021 Tsuruga, Fukui Prefecture, Japan

Heartseed

Health Care
$37M11 Jun 2021 Chiyoda, Japan

better Japan

Accounting
Construction
$910K10 Jun 2021 Chiyoda, Japan

Cake.jp

Delivery Service
E-Commerce
Food Delivery
Internet
$7M10 May 2021 Chiyoda, Japan

Global Trust Networks

Finance
Real Estate
Recruiting
$4M28 Mar 2021 Chiyoda, Japan

PETOKOTO

Pet
09 Mar 2021 Japan, Yamaguchi Prefecture, Japan

TrustHub

Collectibles
E-Commerce
Marketplace
Trading Platform
$3M26 Feb 2021 Chiyoda, Japan
News
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure

– Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), announced it has raised 4 Billion-yen (approx. $37 Million) at Series C round, bringing its total financial backing to 8.2 Billion yen (approx. $75 Million) since its foundation in 2015.
– New investors are UTokyo Innovation Platform Co. (UTokyo IPC), Medical Incubator Japan, Keio Innovation Initiative (KII), and Sumitomo Mitsui Trust Investment. Among the existing investors, SBI Group, Nissay Capital, SMBC Capital, Medipal Holdings, and Itochu Chemical Frontier participated in this round.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Nissay Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: